NCT00259116View on ClinicalTrials.gov

A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2005

Conditions
Heart Failure, Congestive
Interventions
DRUG

Relaxin

Trial Locations (1)

10117

Charite Hospital, Berlin

All Listed Sponsors
lead

Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies

INDUSTRY

NCT00259116 - A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure | Biotech Hunter | Biotech Hunter